http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104230913-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a239a641f694acd5245e5dfe52368de9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate | 2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a2df87a681e44e2c3f3bcc89566dfd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_656235dc9a70ef05600e710196a4d73f |
| publicationDate | 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104230913-A |
| titleOfInvention | Piperazine-substituted quinazoline compounds and uses thereof |
| abstract | The invention provides a preparation method and application of quinazoline compounds, which are piperazine-substituted quinazoline compounds with general formula I. The piperazine-substituted quinazoline compounds of general formula I of the present invention and pharmaceutically acceptable salts or solvates thereof are effective on human lung cancer cells, human gastric cancer cells, human prostate cancer cells, human colon cancer cells, human kidney cancer cells and The myeloma cells have significant inhibitory effect and can be used for preparing medicines for treating human lung cancer, human stomach cancer, human prostate cancer, human colon cancer, human kidney cancer and myeloma. |
| priorityDate | 2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.